Hammerman, A. (2015) “The ‘real-life’ impact of adding bevacizumab to first-line therapy in metastatic colorectal cancer patients: A large Israeli retrospective cohort study”, Acta Oncologica, 54(2), pp. 164–170. doi: 10.3109/0284186X.2014.958532.